➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Dow
Boehringer Ingelheim
Mallinckrodt
Harvard Business School

Last Updated: October 26, 2021

DrugPatentWatch Database Preview

Teva Pharms Usa Inc Company Profile


Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for TEVA PHARMS USA INC, and what generic and branded alternatives to TEVA PHARMS USA INC drugs are available?

TEVA PHARMS USA INC has sixteen approved drugs.

There are nine tentative approvals on TEVA PHARMS USA INC drugs.

Summary for Teva Pharms Usa Inc
US Patents:0
Tradenames:15
Ingredients:15
NDAs:16

Drugs and US Patents for Teva Pharms Usa Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms Usa Inc POTASSIUM CITRATE potassium citrate TABLET, EXTENDED RELEASE;ORAL 209758-003 Mar 5, 2018 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Teva Pharms Usa Inc MIFEPRISTONE mifepristone TABLET;ORAL 211436-001 Aug 3, 2020 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Teva Pharms Usa Inc TIOPRONIN tiopronin TABLET;ORAL 214326-001 Apr 26, 2021 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Teva Pharms Usa Inc ERLOTINIB HYDROCHLORIDE erlotinib hydrochloride TABLET;ORAL 091059-002 Aug 28, 2015 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Teva Pharms Usa Inc ETHINYL ESTRADIOL; ETONOGESTREL ethinyl estradiol; etonogestrel RING;VAGINAL 204305-001 Jan 13, 2021 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Teva Pharms Usa Inc ERYTHROMYCIN erythromycin TABLET;ORAL 214549-001 Feb 11, 2021 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Teva Pharms Usa Inc FORMOTEROL FUMARATE formoterol fumarate SOLUTION;INHALATION 091141-001 Jun 22, 2021 AN RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for TEVA PHARMS USA INC drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe for Injection 200 mcg/vial ➤ Subscribe 2015-05-01
➤ Subscribe for Injection 100 mcg/vial and 500 mcg/vial ➤ Subscribe 2015-04-14
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Johnson and Johnson
AstraZeneca
Harvard Business School
Colorcon
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.